• Catheter Precision expanded LockeT commercialization across Latin America following a Brazil launch in August 2026.
• LockeT reached six hospitals in Brazil since the São Paulo rollout under a distribution agreement with Ablacor.
• An experienced cardiology group was engaged to support market entry efforts across Argentina, Chile, Colombia.
• Expansion targets additional Latin American countries as part of a broader push to grow international commercial reach in cardiac electrophysiology.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Catheter Precision Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609170800PRIMZONEFULLFEED9828659) on September 17, 2026, and is solely responsible for the information contained therein.